Skip to main content
AIMOVIG 140 mg/mL injection, solution by Amgen, Inc
AIMOVIG, 140 mg/mL, injection, solution Available on prescription only. Listed by Amgen, Inc.
Prescription only

AIMOVIG

erenumab-aooe

Listed by Amgen, Inc

Strength
140 mg/mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Erenumab 140 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 55513-842
FDA application BLA761077
RxNorm concept 2045627
Package sizes listed 1
Marketed since March 2019

Other products containing Erenumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

AIMOVIG

erenumab-aooe

Strength
70 mg/mL
Form
Injection
Rx only

Amgen, Inc

Not stocked by us — reference only

AIMOVIG

erenumab-aooe

Strength
140 mg/mL
Form
Injection, Solution
Rx only

Amgen, Inc

Not stocked by us — reference only

AIMOVIG

erenumab-aooe

Strength
70 mg/mL
Form
Injection
Rx only

Amgen, Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.